PMV Pharmaceuticals (PMVP) Other Non-Current Liabilities (2019)

PMV Pharmaceuticals' (PMVP) quarterly Other Non-Current Liabilities came in at $51000.0 in Q4 2019.

PMV Pharmaceuticals (PMVP) Other Non-Current Liabilities (2019) Analysis & Trends

PMV Pharmaceuticals (PMVP) has 1 years of Other Non-Current Liabilities data on file, last reported at $51000.0 in Q4 2019.

Quarterly Other Non-Current Liabilities changed N/A year-over-year to $51000.0 in Q4 2019, while the trailing twelve-month figure through Dec 2019 was $51000.0 (changed N/A YoY) and the FY2019 annual result came in at $51000.0, changed N/A from the prior year.
Other Non-Current Liabilities was little changed at $51000.0 in Q4 2019.
In the past five years, Other Non-Current Liabilities ranged from a high of $51000.0 in Q4 2019 to a low of $51000.0 in Q4 2019.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn
9	Royalty Pharma	27.27 Bn	26.43 Bn	-
10	PMV Pharmaceuticals	70.74 Mn	-8.69 Mn	-

Download Data

Date	Value
Dec 31, 2019	51,000.00